Telemus Capital, LLC Keros Therapeutics, Inc. Transaction History

Telemus Capital, LLC

  • $1.2 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021
SELL
$36.0 - $82.74 $540,000 - $1.24 Million
-15,000 Closed
0 $0
Q3 2020

Nov 02, 2020
BUY
$27.04 - $62.21 $135,200 - $311,050
5,000 Added 50.0%
15,000 $775,000
Q2 2020

Jul 17, 2020
BUY
$20.08 - $40.39 $200,799 - $403,900
10,000 New
10,000 $328,000

Others Institutions Holding KROS

# of Institutions
153
Shares Held
26.7M
Call Options Held
47.6K
Put Options Held
34.5K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.18B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email